Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-11 11:19 am Purchase | 2022-02-14 | 13G | Gracell Biotechnologies Inc. GRCL | Capital International Investors | 20,318,820 6.000% | 20,318,820 (New Position) | Filing History |
| 2022-02-09 12:17 pm Purchase | 2021-12-31 | 13G | Gracell Biotechnologies Inc. GRCL | LAV Biosciences Fund V L.P. | 25,406,680 7.800% | 25,406,680 (New Position) | Filing History |
| 2022-02-04 09:06 am Purchase | 2021-12-31 | 13G | Gracell Biotechnologies Inc. GRCL | WELLINGTON MANAGEMENT GROUP LLP | 21,460,705 6.360% | 21,460,705 (New Position) | Filing History |
| 2021-01-21 4:46 pm Purchase | 2021-01-12 | 13D | Gracell Biotechnologies Inc. GRCL | ORBIMED ADVISORS LLC | 29,853,364 9.100% | 29,853,364 (New Position) | Filing History |
| 2021-01-15 08:00 am Purchase | 2021-01-07 | 13G | Gracell Biotechnologies Inc. GRCL | Temasek Holdings (Private) Ltd | 49,509,702 15.100% | 49,509,702 (New Position) | Filing History |